<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Celgene Corporation

    Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global ...

    Celgene Corporation, headquartered in Summit, N...

    Filing Type:    PU
    Kaleido Biosciences, Inc.

    Kaleido Biosciences, Inc.

    Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, ...

    Kaleido Biosciences is a clinical-stage healthc...

    Filing Type:    PU
    SeaSpine Holdings Corporation

    SeaSpine Holdings Corporation

    We are a global medical technology company focused on the design, development and ...

    We are a global medical technology company focu...

    Filing Type:    PU
    Celldex Therapeutics, Inc.

    Celldex Therapeutics, Inc.

    Celldex is developing targeted therapeutics to address devastating diseases for wh...

    Celldex is developing targeted therapeutics to ...

    Filing Type:    PU
    InnaMed, Inc.

    InnaMed, Inc.

    InnaMed is developing a comprehensive care management platform. Our team is develo...

    InnaMed is developing a comprehensive care mana...

    Amount Raised:    $1,070,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Otsuka Holdings Co. Ltd.

    Otsuka Holdings Co. Ltd.

    Otsuka Holdings Co Ltd is a pharmaceutical company. The Company manufactures, sell...

    Otsuka Holdings Co Ltd is a pharmaceutical comp...

    Filing Type:    PU
    Enochian Biosciences, Inc.

    Enochian Biosciences, Inc.

    Enochian Biosciences is a pre-clinical stage biotechnology company committed to us...

    Enochian Biosciences is a pre-clinical stage bi...

    Filing Type:    PU
    Turning Point Therapeutics, Inc.

    Turning Point Therapeutics, Inc.

    Turning Point Therapeutics is a clinical-stage precision oncology company with a p...

    Turning Point Therapeutics is a clinical-stage ...

    Filing Type:    PU
    NovoCure Limited

    NovoCure Limited

    Novocure is a global oncology company working to extend survival in some of the mo...

    Novocure is a global oncology company working t...

    Filing Type:    PU
    BeiGene, Ltd.

    BeiGene, Ltd.

    BeiGene, Ltd. (“BeiGene”) is a commercial-stage biotechnology company focused ...

    BeiGene, Ltd. (“BeiGene”) is a commercial-s...

    Filing Type:    PU
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.